✦ LIBER ✦

Preliminary data of a phase II randomized trial of taxotere (TXT) and doxorubicin (DOX) given simultaneously or sequentially as 1st line chemotherapy (CT) for metastatic breast cancer (MBC)

✍ Scribed by Koroleva, I.; Wojtukiewicz, M.; Zaluski, J.; Korytova, L.; Biakhov, M.; Gadel-Mawla, N.; Gouda, Y.; Krishtopin, V.; Dubois, C.; Blanc, C.

Book ID: 123342840
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 152 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81688-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of taxotere (TXT) 100 o

A phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (PTS) with metastatic breast cancer (mbc) with stratification according to prognosis factors

✍ Malik, I.; Roth, A.; Ghilezan, N.; Cufer, T.; Lazarev, A.; Doval, D.; Ionescu-Go 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

407 POSTER A single institution randomiz

407 POSTER A single institution randomized trial of taxotere (T) and xeloda (X) given in combination vs. taxotere (t) followed by xeloda (x) after progression as first line chemotherapy (CT) for metastatic breast cancer (MBC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB